# Nelson Leung

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nelson-leung/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,976 |
| Field | Amyloidosis: Diagnosis, Treatment, Outcomes |
| h-index | 95 |
| i10-index | 449 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5016853434 |
| ORCID iD | https://orcid.org/0000-0002-5651-1411 |
| Works | 1,020 |

## Researcher papers

- [Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy](https://scholariq.org/papers/rituximab-or-cyclosporine-in-the-treatment-of-membranous-nephropathy/)
- [The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group](https://scholariq.org/papers/the-evaluation-of-monoclonal-gammopathy-of-renal-significance-a-consensus-report/)
- [Diagnosis of monoclonal gammopathy of renal significance](https://scholariq.org/papers/diagnosis-of-monoclonal-gammopathy-of-renal-significance/)
- [Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN](https://scholariq.org/papers/mayo-clinic-renal-pathology-society-consensus-report-on-pathologic/)
- [Rituximab Therapy in Idiopathic Membranous Nephropathy](https://scholariq.org/papers/rituximab-therapy-in-idiopathic-membranous-nephropathy/)
- [A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction](https://scholariq.org/papers/a-randomized-controlled-trial-of-rituximab-in-iga-nephropathy-with-proteinuria/)
- [Rituximab treatment of idiopathic membranous nephropathy](https://scholariq.org/papers/rituximab-treatment-of-idiopathic-membranous-nephropathy/)
- [C3 Glomerulonephritis Associated With Monoclonal Gammopathy: A Case Series](https://scholariq.org/papers/c3-glomerulonephritis-associated-with-monoclonal-gammopathy-a-case-series/)
- [DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis](https://scholariq.org/papers/dnajb9-is-a-specific-immunohistochemical-marker-for-fibrillary/)

## Researcher topics

- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.